AstraZeneca Turns Down Pfizer's Sweetened $118B Bid
AstraZeneca PLC has rebuffed a sweetened $118 billion bid to be taken over by Pfizer Inc., again arguing that the offer undervalued it, AstraZeneca said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article